These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 25596505)

  • 1. Overexpression of blood microRNAs 103a, 30b, and 29a in L-dopa-treated patients with PD.
    Serafin A; Foco L; Zanigni S; Blankenburg H; Picard A; Zanon A; Giannini G; Pichler I; Facheris MF; Cortelli P; Pramstaller PP; Hicks AA; Domingues FS; Schwienbacher C
    Neurology; 2015 Feb; 84(7):645-53. PubMed ID: 25596505
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma and White Blood Cells Show Different miRNA Expression Profiles in Parkinson's Disease.
    Schwienbacher C; Foco L; Picard A; Corradi E; Serafin A; Panzer J; Zanigni S; Blankenburg H; Facheris MF; Giannini G; Falla M; Cortelli P; Pramstaller PP; Hicks AA
    J Mol Neurosci; 2017 Jun; 62(2):244-254. PubMed ID: 28540642
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Downregulation of blood serum microRNA 29 family in patients with Parkinson's disease.
    Bai X; Tang Y; Yu M; Wu L; Liu F; Ni J; Wang Z; Wang J; Fei J; Wang W; Huang F; Wang J
    Sci Rep; 2017 Jul; 7(1):5411. PubMed ID: 28710399
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression Profiling of Blood microRNAs 885, 361, and 17 in the Patients with the Parkinson's disease: Integrating Interaction Data to Uncover the Possible Triggering Age-Related Mechanisms.
    Behbahanipour M; Peymani M; Salari M; Hashemi MS; Nasr-Esfahani MH; Ghaedi K
    Sci Rep; 2019 Sep; 9(1):13759. PubMed ID: 31551498
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of a set of endogenous reference genes for miRNA expression studies in Parkinson's disease blood samples.
    Serafin A; Foco L; Blankenburg H; Picard A; Zanigni S; Zanon A; Pramstaller PP; Hicks AA; Schwienbacher C
    BMC Res Notes; 2014 Oct; 7():715. PubMed ID: 25304816
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of plasma microRNA expression changes in multiple system atrophy and Parkinson's disease.
    Uwatoko H; Hama Y; Iwata IT; Shirai S; Matsushima M; Yabe I; Utsumi J; Sasaki H
    Mol Brain; 2019 May; 12(1):49. PubMed ID: 31088501
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validation of differentially expressed brain-enriched microRNAs in the plasma of PD patients.
    Ravanidis S; Bougea A; Papagiannakis N; Koros C; Simitsi AM; Pachi I; Breza M; Stefanis L; Doxakis E
    Ann Clin Transl Neurol; 2020 Sep; 7(9):1594-1607. PubMed ID: 32860338
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevated plasma miR-133b and miR-221-3p as biomarkers for early Parkinson's disease.
    Chen Q; Deng N; Lu K; Liao Q; Long X; Gou D; Bi F; Zhou J
    Sci Rep; 2021 Jul; 11(1):15268. PubMed ID: 34315950
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of differential expression profile of miRNA in peripheral blood of patients with lung cancer.
    He Q; Fang Y; Lu F; Pan J; Wang L; Gong W; Fei F; Cui J; Zhong J; Hu R; Liang M; Fang L; Wang H; Yu M; Zhang ZF
    J Clin Lab Anal; 2019 Nov; 33(9):e23003. PubMed ID: 31541491
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevated homocysteine levels in levodopa-treated idiopathic Parkinson's disease: a meta-analysis.
    Hu XW; Qin SM; Li D; Hu LF; Liu CF
    Acta Neurol Scand; 2013 Aug; 128(2):73-82. PubMed ID: 23432663
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deregulation of microRNA expression in purified T and B lymphocytes from patients with primary Sjögren's syndrome.
    Wang-Renault SF; Boudaoud S; Nocturne G; Roche E; Sigrist N; Daviaud C; Bugge Tinggaard A; Renault V; Deleuze JF; Mariette X; Tost J
    Ann Rheum Dis; 2018 Jan; 77(1):133-140. PubMed ID: 28916716
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Whole blood microRNA expression pattern differentiates patients with rheumatoid arthritis, their seropositive first-degree relatives, and healthy unrelated control subjects.
    Anaparti V; Smolik I; Meng X; Spicer V; Mookherjee N; El-Gabalawy H
    Arthritis Res Ther; 2017 Nov; 19(1):249. PubMed ID: 29126434
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of Deregulated microRNAs and Their Target Genes in Gastric Cancer.
    Juzėnas S; Saltenienė V; Kupcinskas J; Link A; Kiudelis G; Jonaitis L; Jarmalaite S; Kupcinskas L; Malfertheiner P; Skieceviciene J
    PLoS One; 2015; 10(7):e0132327. PubMed ID: 26172537
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aberrant expression of microRNAs in peripheral blood mononuclear cells as candidate biomarkers in patients with axial spondyloarthritis.
    Li X; Lv Q; Tu L; Zhao M; Zhang P; Li Q; Wei Q; Cao S; Gu J
    Int J Rheum Dis; 2019 Jul; 22(7):1188-1195. PubMed ID: 30990253
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum microRNA expression levels in Turkish patients with Parkinson's disease.
    Ozdilek B; Demircan B
    Int J Neurosci; 2021 Dec; 131(12):1181-1189. PubMed ID: 32546033
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miRNA expression is highly sensitive to a drug therapy in Parkinson's disease.
    Alieva AKh; Filatova EV; Karabanov AV; Illarioshkin SN; Limborska SA; Shadrina MI; Slominsky PA
    Parkinsonism Relat Disord; 2015 Jan; 21(1):72-4. PubMed ID: 25465742
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetic-pharmacodynamic modeling of levodopa in patients with advanced Parkinson disease.
    Adamiak U; Kaldonska M; Klodowska-Duda G; Wyska E; Safranow K; Bialecka M; Gawronska-Szklarz B
    Clin Neuropharmacol; 2010 May; 33(3):135-41. PubMed ID: 20216409
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of plasma microRNA potentials as a non-invasive biomarker in patients with axial spondyloarthropathy.
    Yildirim T; Yesilada E; Eren F; Apaydin H; Gulbay G
    Eur Rev Med Pharmacol Sci; 2021 Jan; 25(2):620-625. PubMed ID: 33577015
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating MicroRNAs as Potential Molecular Biomarkers for Intracranial Aneurysmal Rupture.
    Supriya M; Christopher R; Indira Devi B; Bhat DI; Shukla D
    Mol Diagn Ther; 2020 Jun; 24(3):351-364. PubMed ID: 32323261
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential Role of Lipometabolism-Related MicroRNAs in Peripheral Blood Mononuclear Cells as Biomarkers for Coronary Artery Disease.
    Dong J; Liang YZ; Zhang J; Wu LJ; Wang S; Hua Q; Yan YX
    J Atheroscler Thromb; 2017 Apr; 24(4):430-441. PubMed ID: 27629254
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.